Progenics Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
TARRYTOWN, N.Y., April 06, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that Mark R. Baker, CEO, is …